In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives

I. Caleta, M. Grdisa, D. Mrvos-Sermek, M. Cetina, V. K. Tralić-Kulenović, G. Pavelić and G. Karminski-Zamola, Synthesis, crystal structure and antiproliferative evaluation of some new substituted benzothiazoles and styrylbenzothiazoles, Farmaco 59 (2004) 297-305; DOI: 10.1016/j.farmac.2004.01.008.10.1016/j.farmac.2004.01.008Search in Google Scholar

A. I. Loaiza-Péez, V. Trapni, V. Patel, C. Hose, S. S. Singh, J. B. Trepel, M. F. G. Stevens, T. D. Bradshaw and E. A. Sauville, The aryl hydrocarbons receptor mediates sensitivity of MCF-7 breast cancer cells to the antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole, Mol. Pharmacol. 61 (2002) 13-19.10.1124/mol.61.1.13Search in Google Scholar

V. Trapani, V. Patel, C.-O. Leong, H. P. Ciolino, G. C. Yeh, C. Hose, J. B. Trepel, M. F. G. Stevens, E. A. Sausville and A. I. Loaiza-Pérez, DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells, Br. J. Cancer 88 (2003) 599-605; DOI:10.1038/sj.bjc.660072210.1038/sj.bjc.6600722Search in Google Scholar

G. Mortimer, G. Wells, J.-P. Grochard, E. L. Stone, T. D. Bradshaw, M. F. G. Stevens and A. D. Westwell, Antitumor benzothiazoles. 26. 2-(3,4-dimethoxyphenyl)-5-fluoro benzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potents and selective inhibitory activity against lung, colon, and breast cancer cell lines, J. Med. Chem. 49 (2006) 179-185; DOI: 10.1021/jm050942k.10.1021/jm050942kSearch in Google Scholar

G. Wells, J. M. Berry, T. D. Bradshaw, A. M. Burger, A. Seaton, B. Wang, A. D. Westwell and M. F. G. Stevens, Substituted -4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines, J. Med. Chem. 46 (2003) 532-541; DOI:10.1021/jm020984y.10.1021/jm020984ySearch in Google Scholar

T. D. Bradshaw and A. D. Westwell, The development of the antitumor benzothiazole prodrug, Phortress, as a clinical candidate, Curr. Med. Chem. 11 (2004) 1009-1021.10.2174/0929867043455530Search in Google Scholar

M. Yoshida, I. Hayakawa, N. Hayashi, T. Agatsuma, Y. Oda, F. Tanzawa, S. Iwasaki, K. Koyama, H. Furukawa, S. Kurakata and Y. Sugano, Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents, Bioorg. Med. Chem. Lett. 15 (2005) 3328-3333; DOI:10. 1016/j.bmcl.2005.05.077.10.1016/j.bmcl.2005.05.077Search in Google Scholar

I. Hutchinson, T. D. Bradshaw, C. S. Matthews, M. F. G. Stevens and A. D. Westwell, Antitumour benzothiazoles. Part 20: 3'-cyano and 3'-alkynyl-substituted 2-(4'-aminophenyl)benzothiazoles as new potent and selective analogues, Bioorg. Med. Chem. Lett. 13 (2003) 471-474; DOI: 10.1016/S0960-894X(02)00930-7.10.1016/S0960-894X(02)00930-7Search in Google Scholar

T. Akhtar, M. K. Rauf, M. Ebihara and S. Hameed, 2-(3,4-Dichlorophenoxy)propionic acid. Acta Cryst. E63 (2007) 2590-2592; DOI: 10.1107/S1600536807014249.10.1107/S1600536807014249Search in Google Scholar

R. Moumne, S. Lavielle and P. Karoyan, Efficient synthesis of 2-amino acid by homologation of β²-amino acids involving the reformatsky reaction and mannich-type imminium electrophile, J. Org. Chem. 71 (2006) 3332-3334; DOI: 10.1021/jo060316a.10.1021/jo060316a16599644Search in Google Scholar

M. C. Alley, D. A. Scudiero, A. Monks, M. L. Hursey, M. J. Czerwinski, D. L. Fine, B. J. Abbott, L. G. Mayo, R. H. Schoemaker and M. R. Boyd, Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay, Cancer Res. 48 (1988) 589-601.Search in Google Scholar

G. Yang, L. Xu, and A. Lu, Synthesis and bioactivity of novel triazolo [1,5-a]pyrimidine derivatives, Heteroatom Chem. 12 (2001) 491-498; DOI: 10.1002/hc.1075.10.1002/hc.1075Search in Google Scholar

S. D. Young, S. F. Britcher, L. O. Tran, L. S. Payne, W. C. Lumma, T. A. Lyle, J. R. Huff, P. S. Anderson, D. B. Olsen, S. S. Carroll, D. J. Pettibone, J. A. Obrien, R. G. Ball, S. K. Balani, J. H. Lin, I. W. Chen, W. A. Schleif, V. V. Sardana, W. J. Long, V. W. Byrnes and E. A. Emini, Novel, highly potent non-nucleoside inhibitor of the human immunodeficiency-virus type-1 reverse transcriptase, Antimicrob. Agents Chemother. 39 (1995) 2602-2605.10.1128/AAC.39.12.2602Search in Google Scholar

E. De Clercq, Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections, Clin. Microbiol. Rev. 16 (2003) 569-596; DOI: 10.1128/CMR.16.4.Search in Google Scholar

R. B. Weiss, The anthracyclines: will we never find a better docorubicin, 19 (1992) 670-686.Search in Google Scholar

C. D. Hose, M. Hollingshead, E. A. Sauville and A. Monks, Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothizole: A potential surrogate marker for patient sensitivity, Mol. Cancer Ther. 2 (2003) 1265-1272.Search in Google Scholar

D. Shi, T. D. Bradshaw, S. Wrigley, C. J. McCall, P. Lelieveld, I. Fichtner and M. F. G. Stevens, Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo, J. Med. Chem. 39 (1996) 3375-3384; DOI:10.1021/jm9600959.10.1021/jm9600959Search in Google Scholar

T. D. Bradshaw, S. Wrigley, R. J. Schultz, K. D. Paull and M. F. G. Stevens, 2-(4-Aminophenyl) benzothiazoles: novel agents with selective profiles of in vitro antitumor activity, Br. J. Cancer 77 (1998) 745-752.Search in Google Scholar

A. Rana, N. Siddiqui and S. A. Khan, Benzothiazoles: a new profile of biological activities, Indian J. Pharm Sci. 69 (2007) 10-17.Search in Google Scholar

G. Trapani, M. Franco, A. Latrofa, A. Reho and G. Liso, Synthesis, in vitro and in vivo cytotoxicity, and prediction of the intestinal absorption of substituted 2-ethoxycarbonyl-imidazo[2,1-b] benzothiazoles, Eur. J. Pharm. Sci. 14 (2001) 209-216; DOI: 10.1016/S0928-0987(01)00173-7.10.1016/S0928-0987(01)00173-7Search in Google Scholar

K. J. Watson, D. R. Anderson and S. T. Nguyen, Toward polymeric anticancer drug cocktails from ring-opening metathesis polymerization, Macromolecules 34 (2001) 3507-3509; DOI:10.1016/S0928-0987(01)00173-7.10.1016/S0928-0987(01)00173-7Search in Google Scholar